<DOC>
	<DOC>NCT00872573</DOC>
	<brief_summary>The purpose of this study is to monitor the stability of the C-Stem™ AMT hip within the thigh bone when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical, standard x-ray assessments and special x-rays which allow the stability of the implant to be determined.</brief_summary>
	<brief_title>A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip Replacement</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation, Congenital</mesh_term>
	<mesh_term>Slipped Capital Femoral Epiphyses</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<criteria>i) Male or female subjects, aged between 60 and 80 years inclusive. ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained. iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, cooperate with the investigational procedures and are willing to return to the hospital for all the required postoperative followups. iv) Subjects undergoing primary total hip replacement that are considered suitable for a cemented femoral stem and metal femoral head and an all polyethylene acetabular cup. i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and followup in this study. ii) Subjects undergoing revision hip replacement iii) Subjects undergoing simultaneous bilateral hip replacements. iv) Subjects with a contralateral hip replacement, which was implanted less than six months previously or is not performing satisfactorily. v) Women who are pregnant. vi) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect followup care or treatment outcomes. vii) Subjects who have participated in a clinical study with an investigational product in the last 12 months. viii) Subjects who are currently involved in any injury litigation claims.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Hip</keyword>
	<keyword>Cemented</keyword>
</DOC>